bioMérieux exhibits its latest diagnostic innovations at ADLM 2026
bioMérieux to showcase integrated microbiology, molecular diagnostics, mass spectrometry, and laboratory informatics solutions
28 Jul 2026
bioMérieux will showcase its latest diagnostic solutions and innovations at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Conference & Clinical Lab Expo, taking place in Anaheim, California. At booth 2501 in Hall B, attendees can explore bioMérieux technologies spanning clinical microbiology, molecular diagnostics, and laboratory informatics, and learn how these solutions support laboratories and healthcare providers in improving patient care.
bioMérieux’s presence at ADLM 2026 is anchored by the theme: ‘A legacy of diagnostic leadership. Your partner for what’s ahead.’ This reflects the company’s commitment to advancing diagnostic excellence while helping laboratories and healthcare practitioners navigate the future of medicine.
bioMérieux will highlight a range of platforms that demonstrate its end-to-end laboratory ecosystem, including:
- BIOFIRE® FILMARRAY® TORCH System – a multiplex PCR technology that tests for a comprehensive group of targets in about an hour.
- BIOFIRE® SPOTFIRE® System – a multiplex PCR platform that brings reliable diagnostics to point-of-care clinical settings.
- VITEK® MS PRIME – a mass spectrometry system for routine microbial identification.
- VIDAS® 3 – an automated benchtop immunoassay system.
Visitors will be able to explore how bioMérieux solutions help laboratories improve efficiency, accelerate decision-making, and optimize patient care. Attendees can also learn about bioMérieux data and IT solutions and Lab Consultancy offerings, designed to help laboratories optimize operations, improve outcomes, and drive digital transformation.
Educational symposiums
bioMérieux will host two symposiums included in the ADLM 2026 conference agenda:
From Central Lab to POC: Rethinking Vaginitis Diagnostics
- When: Tuesday, July 28, 12–12:20 PDT
- Where: Exhibit Hall Theater 2
- What to expect: Attendees will examine current diagnostic limitations, the consequences of delayed results, and how point-of-care testing aligns with real-time decision making.
The Syndromic Standard: Explore the Clinical Impact of MPCR GI Panels for Gastroenteritis
- When: Tuesday, July 28, 14:45–15:35 PDT
- Where: Exhibit Hall Theater 1
- What to expect: Attendees will learn about the latest developments in reducing diagnostic uncertainty, improving time-to-treatment, and advancing patient outcomes.
Press conference and panel discussion
bioMérieux will also host a press conference panel, ‘The Power of Diagnostics: How Delays Impact Patients and Providers,’ on Wednesday, July 29, from 9:00–9:45 PDT in room 213D.
Panel experts from bioMérieux, rural medicine, and patient advocacy will discuss the real-world impacts of delayed or inaccurate diagnostic answers for patients, providers, communities, and the healthcare system, with a particular focus on women, minority communities, and other underserved populations. The panel will feature real-world examples from patient and provider experiences and explore potential solutions for both current and future diagnostic challenges.
Follow SelectScience throughout ADLM 2026 for exclusive interviews, daily round-up articles, Scientists' Choice Awards® coverage, and the latest news from the exhibition floor.
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Links
Tags
Frequently asked questions
Show frequently asked questions
What diagnostic technologies will bioMérieux showcase at the 2026 ADLM Annual Conference & Clinical Lab Expo in Anaheim?
bioMérieux will showcase an end-to-end laboratory ecosystem at ADLM 2026, booth 2501 in Hall B. Featured platforms include the BIOFIRE® FILMARRAY® TORCH System, BIOFIRE® SPOTFIRE® System, VITEK® MS PRIME, and VIDAS® 3. These solutions span clinical microbiology, molecular diagnostics, immunoassays, laboratory automation, informatics, and stewardship initiatives to help laboratories improve efficiency and patient care.
How do bioMérieux’s BIOFIRE multiplex PCR systems support point-of-care and central lab diagnostics for conditions like vaginitis and gastroenteritis?
BIOFIRE® FILMARRAY® TORCH and BIOFIRE® SPOTFIRE® multiplex PCR systems test comprehensive target groups in about an hour and bring reliable diagnostics to point-of-care settings. Symposiums on vaginitis diagnostics and MPCR GI panels for gastroenteritis will explore reducing diagnostic limitations, uncertainty, and time-to-treatment to advance real-time decision making and patient outcomes.
What topics will be covered in bioMérieux’s ADLM 2026 symposiums and press conference on the impact of diagnostic delays?
bioMérieux’s ADLM 2026 symposiums will address rethinking vaginitis diagnostics from central lab to point-of-care and the clinical impact of MPCR GI panels for gastroenteritis. A press conference, ‘The Power of Diagnostics: How Delays Impact Patients and Providers,’ will examine real-world consequences of delayed or inaccurate diagnostics, especially for women, minority communities, and underserved populations, and discuss potential solutions.